Package 0310-0088-39

{"route": ["ORAL"], "spl_id": "11cd495f-c5cf-4076-b69c-af202ec2a8a1", "openfda": {"nui": ["N0000182961", "N0000182960"], "unii": ["0P6C6ZOP5U"], "rxcui": ["1091839", "1091843", "2001319", "2001321"], "spl_set_id": ["c9a1d0a8-581f-4f91-a2b8-f419192d0ebf"], "pharm_class_epc": ["Phosphodiesterase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 4 Inhibitors [MoA]"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-28)  / 28 TABLET in 1 BLISTER PACK", "package_ndc": "0310-0088-28", "marketing_start_date": "20180123"}, {"sample": false, "description": "10 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-39)  / 2 TABLET in 1 BLISTER PACK", "package_ndc": "0310-0088-39", "marketing_start_date": "20180123"}], "brand_name": "Daliresp", "product_id": "0310-0088_11cd495f-c5cf-4076-b69c-af202ec2a8a1", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 4 Inhibitor [EPC]", "Phosphodiesterase 4 Inhibitors [MoA]"], "product_ndc": "0310-0088", "generic_name": "roflumilast", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Daliresp", "active_ingredients": [{"name": "ROFLUMILAST", "strength": "250 ug/1"}], "application_number": "NDA022522", "marketing_category": "NDA", "marketing_start_date": "20150701", "listing_expiration_date": "20261231"}